CO4940412A1 - Antibiotico de carbapenem, composicion y metodo de prepara- cion - Google Patents

Antibiotico de carbapenem, composicion y metodo de prepara- cion

Info

Publication number
CO4940412A1
CO4940412A1 CO97028781A CO97028781A CO4940412A1 CO 4940412 A1 CO4940412 A1 CO 4940412A1 CO 97028781 A CO97028781 A CO 97028781A CO 97028781 A CO97028781 A CO 97028781A CO 4940412 A1 CO4940412 A1 CO 4940412A1
Authority
CO
Colombia
Prior art keywords
preparation
composition
carbapenem antibiotic
carbapenem
antibiotic
Prior art date
Application number
CO97028781A
Other languages
English (en)
Inventor
Jeffrey A Zimmerman
John M Williams
Paul A Bergquist
Lisa M Dimichele
David C Dubost
Michael J Kaufman
Daniel R Sidler
William A Hunke
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940412(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CO4940412A1 publication Critical patent/CO4940412A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una composición farmacéutica que está compuesta de un compuestorepresentado por la fórmula Io una sal farmacéuticamente aceptable, forma estabilizada, prodroga o hidrato del mismo, en combinación con una fuente de dióxido de carbono.
CO97028781A 1996-05-28 1997-05-26 Antibiotico de carbapenem, composicion y metodo de prepara- cion CO4940412A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (1)

Publication Number Publication Date
CO4940412A1 true CO4940412A1 (es) 2000-07-24

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97028781A CO4940412A1 (es) 1996-05-28 1997-05-26 Antibiotico de carbapenem, composicion y metodo de prepara- cion

Country Status (34)

Country Link
EP (1) EP0863901B1 (es)
JP (2) JPH11509871A (es)
KR (2) KR100403497B1 (es)
CN (1) CN1067074C (es)
AT (1) ATE252584T1 (es)
AU (1) AU710102B2 (es)
BG (1) BG63821B1 (es)
CA (1) CA2227994C (es)
CO (1) CO4940412A1 (es)
CY (1) CY2437B1 (es)
CZ (1) CZ296381B6 (es)
DE (1) DE69725696T2 (es)
DK (1) DK0863901T3 (es)
DZ (1) DZ2242A1 (es)
EA (1) EA000534B1 (es)
EE (1) EE04678B1 (es)
ES (1) ES2208907T3 (es)
HK (1) HK1016176A1 (es)
HR (1) HRP970281B1 (es)
HU (1) HU229426B1 (es)
ID (1) ID16974A (es)
IL (1) IL123078A (es)
IS (1) IS2353B (es)
MX (1) MX9800808A (es)
NO (1) NO323815B1 (es)
NZ (1) NZ329649A (es)
PL (1) PL188917B1 (es)
PT (1) PT863901E (es)
RS (1) RS49583B (es)
SI (1) SI0863901T1 (es)
SK (1) SK284359B6 (es)
TR (1) TR199800146T1 (es)
TW (1) TW434014B (es)
WO (1) WO1997045430A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000508343A (ja) * 1996-10-28 2000-07-04 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム抗生物質組成物及びその製造方法
YU65899A (sh) * 1997-06-16 2001-05-28 Merck & Co. Inc. Stabilizovani karbapenem intermedijari i sintetska upotreba
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
DE60017194T2 (de) * 1999-10-29 2005-12-22 Merck & Co., Inc. Verfahren zur herstellung von carbapenem-antibiotika zubereitungen
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
EP2229944A1 (en) 2007-12-12 2010-09-22 Dainippon Sumitomo Pharma Co., Ltd. Preparation composition
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505190A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
EP2415758B1 (en) 2009-03-31 2017-03-01 Mitsubishi Materials Electronic Chemicals Co., Ltd. Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
WO2010151574A2 (en) 2009-06-25 2010-12-29 Shell Oil Company Water injection systems and methods
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
CN104651539B (zh) 2010-11-05 2018-09-28 国际壳牌研究有限公司 处理生物质以产生可用于生物燃料的材料
US8609379B2 (en) 2010-12-20 2013-12-17 Shell Oil Company Process for the production of alcohols from biomass
AU2012352235B2 (en) 2011-12-15 2015-01-15 Shell Internationale Research Maatschappij B.V. Method of treating byproducts from ethanol production
BR112014028024A2 (pt) 2012-05-17 2017-07-25 Shell Int Research método para processar um material de biomassa.
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
WO2015160887A1 (en) 2014-04-17 2015-10-22 Shell Oil Company Processes for producing fermentation products
EP3180320B1 (en) 2014-08-14 2021-01-13 Shell International Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
CY2437B1 (en) 2004-11-12
EP0863901B1 (en) 2003-10-22
HUP9901567A3 (en) 2000-03-28
IS4663A (is) 1998-01-27
JPH11509871A (ja) 1999-08-31
BG102273A (bg) 1998-09-30
CZ296381B6 (cs) 2006-03-15
NO980380L (no) 1998-03-16
WO1997045430A1 (en) 1997-12-04
EE9800022A (et) 1998-08-17
KR100403497B1 (ko) 2003-10-30
DZ2242A1 (fr) 2002-12-18
NO323815B1 (no) 2007-07-09
EE04678B1 (et) 2006-08-15
CN1067074C (zh) 2001-06-13
ES2208907T3 (es) 2004-06-16
SI0863901T1 (en) 2004-04-30
IS2353B (is) 2008-04-15
PL188917B1 (pl) 2005-05-31
AU3077597A (en) 1998-01-05
ID16974A (id) 1997-11-27
AU710102B2 (en) 1999-09-16
CN1198162A (zh) 1998-11-04
KR100344479B1 (ko) 2002-10-31
TW434014B (en) 2001-05-16
PT863901E (pt) 2004-02-27
HRP970281A2 (en) 1998-06-30
ATE252584T1 (de) 2003-11-15
IL123078A (en) 2002-03-10
CZ25398A3 (cs) 1998-07-15
DE69725696D1 (de) 2003-11-27
EA199800180A1 (ru) 1998-08-27
YU4198A (sh) 1998-12-23
EP0863901A1 (en) 1998-09-16
RS49583B (sr) 2007-04-10
DE69725696T2 (de) 2004-07-29
EA000534B1 (ru) 1999-10-28
JP2009084284A (ja) 2009-04-23
HU229426B1 (en) 2013-12-30
HRP970281B1 (en) 2002-04-30
SK284359B6 (sk) 2005-02-04
BG63821B1 (bg) 2003-02-28
MX9800808A (es) 1998-04-30
HUP9901567A2 (hu) 1999-09-28
KR19990036052A (es) 1999-05-25
NZ329649A (en) 1998-11-25
JP5255983B2 (ja) 2013-08-07
PL324746A1 (en) 1998-06-08
SK10998A3 (en) 1998-08-05
CA2227994A1 (en) 1997-12-04
DK0863901T3 (da) 2004-02-16
CA2227994C (en) 2002-06-25
HK1016176A1 (en) 1999-10-29
TR199800146T1 (xx) 1998-06-22
NO980380D0 (no) 1998-01-28
IL123078A0 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
CO4940412A1 (es) Antibiotico de carbapenem, composicion y metodo de prepara- cion
MY115662A (en) Novel compounds with analgesic effect
IL154342A0 (en) A method of analgesia
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
NO307687B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
DE69903053T2 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
AR006284A1 (es) Una composicion farmaceutica de carbapenem, una forma estabilizada del mismo, composiciones farmaceuticas de este compuesto y un metodo paraestabilizar un carbapenem
MX9804797A (es) Nuevos compuestos con efecto analgesico.
CO4770982A1 (es) Nuevas formulaciones